Penumbra (PEN) Cash from Investing Activities (2014 - 2026)

Penumbra's (PEN) quarterly Cash from Investing Activities came in at -$30.6 million in Q1 2026, down 6002.19% year-on-year from $519010.6 in Q1 2025, and up 86.42% on a QoQ basis from -$225.6 million in Q4 2025.

Penumbra (PEN) Cash from Investing Activities (2014 - 2026) Analysis & Trends

Penumbra (PEN) has 13 years of Cash from Investing Activities data on file, last reported at -$30.6 million in Q1 2026.

  • On a quarterly basis, Cash from Investing Activities fell 6002.19% year-over-year to -$30.6 million in Q1 2026; TTM through Mar 2026 was -$434.7 million, a 840.1% decrease from a year earlier, with the FY2025 full-year figure at -$404.6 million, down 621.22% from the prior year.
  • Cash from Investing Activities for Q1 2026 stood at -$30.6 million, up from -$225.6 million in the prior quarter.
  • Over the last five years, Cash from Investing Activities for PEN reached as high as $35.7 million in Q3 2024 and fell as low as -$225.6 million in Q4 2025.
  • Historically, Cash from Investing Activities has averaged -$18.8 million across 5 years, with a median of $8.6 million in 2022.
  • Across the five-year window, Cash from Investing Activities soared 744.73% in 2022 and sank 6002.19% in 2026, its largest moves.
  • Year by year, Cash from Investing Activities stood at $8.6 million in 2022, then soared by 181.25% to $24.3 million in 2023, then tumbled by 145.12% to -$11.0 million in 2024, then slumped by 1959.76% to -$225.6 million in 2025, then surged by 86.42% to -$30.6 million in 2026.
  • Per Business Quant data, the three most recent Cash from Investing Activities figures were -$30.6 million in Q1 2026, -$225.6 million in Q4 2025, and -$162.9 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Activities (Qtr)
1 Abbott Laboratories 184.10 Bn 176.81 Bn 6.27 Bn -20.32 Bn
2 Stryker 128.79 Bn 125.91 Bn 3.81 Bn -185.00 Mn
3 Medtronic 108.97 Bn 99.75 Bn 6.41 Bn -917.00 Mn
4 Boston Scientific 68.57 Bn 67.12 Bn 3.61 Bn -591.00 Mn
5 Edwards Lifesciences 47.64 Bn 43.97 Bn 1.29 Bn -92.80 Mn
6 GE HealthCare Technologies 28.40 Bn 26.11 Bn 1.98 Bn -2.50 Bn
7 Dexcom 28.32 Bn 27.20 Bn 750.30 Mn -298.50 Mn
8 Smith & Nephew 26.94 Bn 26.36 Bn - -
9 Koninklijke Philips 25.45 Bn 22.33 Bn 2.07 Bn -475.32 Mn
10 Penumbra 12.57 Bn 11.95 Bn 253.41 Mn -30.63 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -30.63 Mn
Mar 31, 2026 -30.63 Mn
Dec 31, 2025 -225.65 Mn
Dec 31, 2025 -225.65 Mn
Sep 30, 2025 -162.86 Mn
Sep 30, 2025 -162.86 Mn
Jun 30, 2025 -15.58 Mn
Jun 30, 2025 -15.58 Mn
Mar 31, 2025 -502,000.00
Mar 31, 2025 -502,000.00
Dec 31, 2024 -10.96 Mn
Dec 31, 2024 -10.96 Mn
Sep 30, 2024 35.72 Mn
Sep 30, 2024 35.72 Mn
Jun 30, 2024 34.47 Mn
Jun 30, 2024 34.47 Mn
Mar 31, 2024 18.38 Mn
Mar 31, 2024 18.38 Mn
Dec 31, 2023 24.28 Mn
Dec 31, 2023 24.28 Mn